Home
NTRA
NTRA News

Latest Natera Inc. (NTRA) News on October 30, 2025

Natera Reports Strong Advanced Adenoma Data from Prospective PROCEED-CRC Trial, Demonstrating 22.5% Sensitivity and 91.5% Specificity

Business Wire

2 days ago

Natera Reports Strong Advanced Adenoma Data from Prospective PROCEED-CRC Trial, Demonstrating 22.5% Sensitivity and 91.5% Specificity

Does Signatera’s Positive Phase 3 Data Shift the Long-Term Growth Story for Natera (NTRA)?

Simply Wall St.

2 days ago

Does Signatera’s Positive Phase 3 Data Shift the Long-Term Growth Story for Natera (NTRA)?

How Recent Developments Are Reshaping the Natera Investment Story

Simply Wall St.

2 days ago

How Recent Developments Are Reshaping the Natera Investment Story

Natera (NTRA): Assessing Valuation After Pivotal Clinical Data Boosts FDA Prospects for Signatera

Simply Wall St.

3 days ago

Natera (NTRA): Assessing Valuation After Pivotal Clinical Data Boosts FDA Prospects for Signatera

Reflecting On Immuno-Oncology Stocks’ Q2 Earnings: Natera (NASDAQ:NTRA)

StockStory

9 days ago

Reflecting On Immuno-Oncology Stocks’ Q2 Earnings: Natera (NASDAQ:NTRA)

Why Are Natera (NTRA) Shares Soaring Today

StockStory

10 days ago

Why Are Natera (NTRA) Shares Soaring Today

Successful IMvigor011 Trial Achieves 41% Improvement in Overall Survival for Bladder Cancer Patients

Business Wire

10 days ago

Successful IMvigor011 Trial Achieves 41% Improvement in Overall Survival for Bladder Cancer Patients

The Bull Case For Natera (NTRA) Could Change Following Breakthrough Study Results for Signatera Platform

Simply Wall St.

17 days ago

The Bull Case For Natera (NTRA) Could Change Following Breakthrough Study Results for Signatera Platform

Natera Signatera Validation Study Published in JCO PO Shows Superior Prognostic Value in Testicular Cancer

Insider Monkey

17 days ago

Natera Signatera Validation Study Published in JCO PO Shows Superior Prognostic Value in Testicular Cancer

Natera to Host Investor Call on October 23, 2025 to Discuss ESMO Findings

Business Wire

17 days ago

Natera to Host Investor Call on October 23, 2025 to Discuss ESMO Findings

Natera (NTRA) Valuation: Exploring Upside as Investors Weigh Recent Performance and Long-Term Potential

Simply Wall St.

17 days ago

Natera (NTRA) Valuation: Exploring Upside as Investors Weigh Recent Performance and Long-Term Potential

Natera to Present 14 Studies at ESMO, Including IMvigor011 Oral Presentation in Presidential Symposium

Business Wire

17 days ago

Natera to Present 14 Studies at ESMO, Including IMvigor011 Oral Presentation in Presidential Symposium

2 of Wall Street’s Favorite Stocks on Our Watchlist and 1 That Underwhelm

StockStory

24 days ago

2 of Wall Street’s Favorite Stocks on Our Watchlist and 1 That Underwhelm

Enrollment Tops 1,600 in Natera’s EXPAND Trial of Single Gene NIPT

Business Wire

a month ago

Enrollment Tops 1,600 in Natera’s EXPAND Trial of Single Gene NIPT

Exploring 3 High Growth Tech Stocks In The US Market

Simply Wall St.

a month ago

Exploring 3 High Growth Tech Stocks In The US Market

Natera Announces Publication of Signatera™ Validation Study in Testicular Cancer

Business Wire

a month ago

Natera Announces Publication of Signatera™ Validation Study in Testicular Cancer

Signatera™ Surveillance Testing Identified 100% of Uterine Cancer Recurrences in Advance of Imaging, New Study Shows

Business Wire

a month ago

Signatera™ Surveillance Testing Identified 100% of Uterine Cancer Recurrences in Advance of Imaging, New Study Shows

2 Safe-and-Steady Stocks to Target This Week and 1 Facing Headwinds

StockStory

a month ago

2 Safe-and-Steady Stocks to Target This Week and 1 Facing Headwinds

Humana initiated, Paycom upgraded: Wall Street's top analyst calls

The Fly

a month ago

Humana initiated, Paycom upgraded: Wall Street's top analyst calls

MT Newswires

a month ago

Natera Insider Sold Shares Worth $9,016,668, According to a Recent SEC Filing

Why Natera (NTRA) Stock Is Trading Lower Today

StockStory

2 months ago

Why Natera (NTRA) Stock Is Trading Lower Today

Discover September 2025's Stocks That May Be Trading Below Estimated Value

Simply Wall St.

2 months ago

Discover September 2025's Stocks That May Be Trading Below Estimated Value

Why Natera (NTRA) Shares Are Falling Today

StockStory

2 months ago

Why Natera (NTRA) Shares Are Falling Today

3 Reasons We’re Fans of Natera (NTRA)

StockStory

2 months ago

3 Reasons We’re Fans of Natera (NTRA)

Natera (NTRA): How the ARCHER Trial May Shape Future Valuation After Key Signatera Milestone

Simply Wall St.

2 months ago

Natera (NTRA): How the ARCHER Trial May Shape Future Valuation After Key Signatera Milestone

Liquid Biopsy Market Trends and Industry Forecast to 2030 Featuring Strategic Analysis of Natera, Guardant Health, Myriad Genetics, Illumina, and Roche Among Others

GlobeNewswire

2 months ago

Liquid Biopsy Market Trends and Industry Forecast to 2030 Featuring Strategic Analysis of Natera, Guardant Health, Myriad Genetics, Illumina, and Roche Among Others

Natera (NTRA) Provides an Update on its Intellectual Property Litigation With NeoGenomics

Insider Monkey

2 months ago

Natera (NTRA) Provides an Update on its Intellectual Property Litigation With NeoGenomics

Health Care Roundup: Market Talk

The Wall Street Journal

2 months ago

Health Care Roundup: Market Talk

Why Natera (NTRA) Stock Is Down Today

StockStory

2 months ago

Why Natera (NTRA) Stock Is Down Today

Why Is NeoGenomics (NEO) Stock Soaring Today

StockStory

2 months ago

Why Is NeoGenomics (NEO) Stock Soaring Today

NeoGenomics Gains 'Unexpected' Win As Court Rejects Natera Claims

Benzinga

2 months ago

NeoGenomics Gains 'Unexpected' Win As Court Rejects Natera Claims

MT Newswires

2 months ago

Sector Update: Health Care Stocks Decline Premarket Friday

MT Newswires

2 months ago

Sector Update: Health Care

Natera Provides Update on Patent Litigation with NeoGenomics

Business Wire

2 months ago

Natera Provides Update on Patent Litigation with NeoGenomics

MT Newswires

2 months ago

NeoGenomics Says Court Decides to Invalidate Natera's Asserted Patents; Shares up Pre-Bell

Natera to Present Signatera™ Data at the IASLC World Conference on Lung Cancer

Business Wire

2 months ago

Natera to Present Signatera™ Data at the IASLC World Conference on Lung Cancer

MT Newswires

2 months ago

Natera Introduces AI Models to Speed Up Diagnostic and Therapeutic Innovation

Natera Technology Featured in 300+ Peer-Reviewed Publications, Underscoring Scientific Leadership in Precision Medicine

Business Wire

2 months ago

Natera Technology Featured in 300+ Peer-Reviewed Publications, Underscoring Scientific Leadership in Precision Medicine

Natera Launches Proprietary AI Foundation Models to Accelerate Diagnostic and Therapeutic Innovation

Business Wire

2 months ago

Natera Launches Proprietary AI Foundation Models to Accelerate Diagnostic and Therapeutic Innovation

1 Healthcare Stock to Own for Decades and 2 We Find Risky

StockStory

2 months ago

1 Healthcare Stock to Own for Decades and 2 We Find Risky

Natera (NTRA) Reports Positive Phase III Trial Results in Muscle-Invasive Bladder Cancer

Simply Wall St.

2 months ago

Natera (NTRA) Reports Positive Phase III Trial Results in Muscle-Invasive Bladder Cancer

Natera pursues ctDNA assay approval after Phase III victory

Clinical Trials Arena

2 months ago

Natera pursues ctDNA assay approval after Phase III victory

Natera Gains Medicare Coverage for WGS Signatera, Leerink Reaffirms Price Target

Insider Monkey

4 months ago

Natera Gains Medicare Coverage for WGS Signatera, Leerink Reaffirms Price Target

Q1 Rundown: Regeneron (NASDAQ:REGN) Vs Other Immuno-Oncology Stocks

StockStory

4 months ago

Q1 Rundown: Regeneron (NASDAQ:REGN) Vs Other Immuno-Oncology Stocks

3 Reasons We Love Natera (NTRA)

StockStory

4 months ago

3 Reasons We Love Natera (NTRA)

High Growth US Tech Stocks To Watch In June 2025

Simply Wall St.

4 months ago

High Growth US Tech Stocks To Watch In June 2025

NTRA Q1 Earnings Call: Growth in Oncology and Women's Health Drives Guidance Increase

StockStory

5 months ago

NTRA Q1 Earnings Call: Growth in Oncology and Women's Health Drives Guidance Increase

MT Newswires

5 months ago

Natera Says Signatera Cancer Test Approved for Medicare Coverage

Natera Announces Medicare Coverage for Signatera™ Genome

Business Wire

5 months ago

Natera Announces Medicare Coverage for Signatera™ Genome

Natera (NasdaqGS:NTRA) Showcases 94% Sensitivity In Pan-Cancer Signatera Genome Study

Simply Wall St.

5 months ago

Natera (NasdaqGS:NTRA) Showcases 94% Sensitivity In Pan-Cancer Signatera Genome Study

SignateraTM Genome Clinical Performance Highlighted at ASCO 2025

Business Wire

5 months ago

SignateraTM Genome Clinical Performance Highlighted at ASCO 2025

3 Mid-Cap Stocks Worth Your Attention

StockStory

5 months ago

3 Mid-Cap Stocks Worth Your Attention

Natera to Present over 25 Signatera™ Studies at 2025 ASCO Annual Meeting

Business Wire

5 months ago

Natera to Present over 25 Signatera™ Studies at 2025 ASCO Annual Meeting

Exploring 3 High Growth Tech Stocks In The US Market

Simply Wall St.

5 months ago

Exploring 3 High Growth Tech Stocks In The US Market

3 Stocks That May Be Trading Below Their Estimated Value

Simply Wall St.

5 months ago

3 Stocks That May Be Trading Below Their Estimated Value

Natera, Inc. (NTRA): A Bull Case Theory

Insider Monkey

6 months ago

Natera, Inc. (NTRA): A Bull Case Theory

Natera, Inc. (NASDAQ:NTRA) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

Simply Wall St.

6 months ago

Natera, Inc. (NASDAQ:NTRA) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

Natera First Quarter 2025 Earnings: Beats Expectations

Simply Wall St.

6 months ago

Natera First Quarter 2025 Earnings: Beats Expectations

Thomson Reuters StreetEvents

6 months ago

Q1 2025 Natera Inc Earnings Call

Natera Inc (NTRA) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Raised Guidance

GuruFocus.com

6 months ago

Natera Inc (NTRA) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Raised Guidance

Natera (NTRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

6 months ago

Natera (NTRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Natera (NASDAQ:NTRA) Surprises With Strong Q1, Guides for Strong Full-Year Sales

StockStory

6 months ago

Natera (NASDAQ:NTRA) Surprises With Strong Q1, Guides for Strong Full-Year Sales

Associated Press Finance

6 months ago

Natera: Q1 Earnings Snapshot

Natera Reports First Quarter 2025 Financial Results

Business Wire

6 months ago

Natera Reports First Quarter 2025 Financial Results

Signatera Data From I-SPY 2 Trial to Be Presented at ESMO Breast Annual Congress

Business Wire

6 months ago

Signatera Data From I-SPY 2 Trial to Be Presented at ESMO Breast Annual Congress

Natera Inc (NTRA) Q1 2025: Everything You Need To Know Ahead Of Earnings

GuruFocus.com

6 months ago

Natera Inc (NTRA) Q1 2025: Everything You Need To Know Ahead Of Earnings

Prospera™ Heart Test with DQS Outperforms dd-cfDNA Percentage in Detecting Allograft Rejection, New AJT Publication Shows

Business Wire

6 months ago

Prospera™ Heart Test with DQS Outperforms dd-cfDNA Percentage in Detecting Allograft Rejection, New AJT Publication Shows

What To Expect From Natera’s (NTRA) Q1 Earnings

StockStory

6 months ago

What To Expect From Natera’s (NTRA) Q1 Earnings

Natera reports outcomes from study of MRD test for soft tissue and bone sarcomas

Medical Device Network

6 months ago

Natera reports outcomes from study of MRD test for soft tissue and bone sarcomas

Largest Sarcoma Study to Date with ctDNA Analysis Demonstrates Excellent Performance for Signatera

Business Wire

6 months ago

Largest Sarcoma Study to Date with ctDNA Analysis Demonstrates Excellent Performance for Signatera

Natera to Report its First Quarter Results on May 8, 2025

Business Wire

6 months ago

Natera to Report its First Quarter Results on May 8, 2025

Natera (NasdaqGS:NTRA) Unveils DEFINE-HT Trial Insights in Heart Transplantation Study

Simply Wall St.

6 months ago

Natera (NasdaqGS:NTRA) Unveils DEFINE-HT Trial Insights in Heart Transplantation Study

Prospective DEFINE-HT Study Demonstrates that Prospera™ Heart is Predictive of Clinical Outcomes and Outperforms Biopsy in Predicting Graft Dysfunction

Business Wire

6 months ago

Prospective DEFINE-HT Study Demonstrates that Prospera™ Heart is Predictive of Clinical Outcomes and Outperforms Biopsy in Predicting Graft Dysfunction

2 Healthcare Stocks on Our Watchlist and 1 to Be Wary Of

StockStory

6 months ago

2 Healthcare Stocks on Our Watchlist and 1 to Be Wary Of

2 Healthcare Stocks on Our Watchlist and 1 to Be Wary Of

StockStory

6 months ago

2 Healthcare Stocks on Our Watchlist and 1 to Be Wary Of

Natera, Inc. (NTRA): One of the Best Aggressive Growth Stocks to Buy Now

Insider Monkey

6 months ago

Natera, Inc. (NTRA): One of the Best Aggressive Growth Stocks to Buy Now

Natera Announces Broad Clinical Launch of Ultra-Sensitive Signatera™ Genome MRD Test

Business Wire

6 months ago

Natera Announces Broad Clinical Launch of Ultra-Sensitive Signatera™ Genome MRD Test

Natera To Present Data from 8 Studies at 2025 AACR Annual Meeting

Business Wire

6 months ago

Natera To Present Data from 8 Studies at 2025 AACR Annual Meeting

The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.

Investor's Business Daily

6 months ago

The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.

3 Top Stocks Estimated To Trade At Up To 48.4% Below Intrinsic Value

Simply Wall St.

6 months ago

3 Top Stocks Estimated To Trade At Up To 48.4% Below Intrinsic Value

Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers

StockStory

6 months ago

Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers

High Growth Tech Stocks In US With Potential For Expansion

Simply Wall St.

7 months ago

High Growth Tech Stocks In US With Potential For Expansion

Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)

StockStory

7 months ago

Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)

Natera (NasdaqGS:NTRA) Climbs 11% in One Week

Simply Wall St.

7 months ago

Natera (NasdaqGS:NTRA) Climbs 11% in One Week

When Will Natera, Inc. (NASDAQ:NTRA) Turn A Profit?

Simply Wall St.

7 months ago

When Will Natera, Inc. (NASDAQ:NTRA) Turn A Profit?

Natera, Inc. (NTRA): Among Stocks with Buy Ratings that Hedge Funds Love

Insider Monkey

7 months ago

Natera, Inc. (NTRA): Among Stocks with Buy Ratings that Hedge Funds Love

3 Reasons NTRA Has Explosive Upside Potential

StockStory

7 months ago

3 Reasons NTRA Has Explosive Upside Potential

27.5% of Stanley Druckenmiller's $3.7 Billion Portfolio Is Invested in These 3 Under-the-Radar AI Stocks

Motley Fool

7 months ago

27.5% of Stanley Druckenmiller's $3.7 Billion Portfolio Is Invested in These 3 Under-the-Radar AI Stocks

Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)

StockStory

7 months ago

Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)

DEFINE-HT Selected for Late-Breaking Oral Presentation at ISHLT Annual Meeting

Business Wire

7 months ago

DEFINE-HT Selected for Late-Breaking Oral Presentation at ISHLT Annual Meeting

Is Natera, Inc. (NTRA) the Best Diagnostics Stock to Invest in Right Now?

Insider Monkey

7 months ago

Is Natera, Inc. (NTRA) the Best Diagnostics Stock to Invest in Right Now?

Here’s What Lifted Natera (NTRA) in Q4 and 2024

Insider Monkey

7 months ago

Here’s What Lifted Natera (NTRA) in Q4 and 2024

Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack

StockStory

7 months ago

Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack

Is Natera (NTRA) the Best Biotech Stock According to Billionaires?

Insider Monkey

7 months ago

Is Natera (NTRA) the Best Biotech Stock According to Billionaires?

Argus Research

7 months ago

Daily – Vickers Top Buyers & Sellers for 03/17/2025

Natera And 2 Other Stocks That May Be Trading Below Their Estimated Value

Simply Wall St.

8 months ago

Natera And 2 Other Stocks That May Be Trading Below Their Estimated Value

Exploring Three High Growth Tech Stocks In The US Market

Simply Wall St.

8 months ago

Exploring Three High Growth Tech Stocks In The US Market

Natera (NasdaqGS:NTRA) Welcomes Former National Cancer Institute Director Back to Board

Simply Wall St.

8 months ago

Natera (NasdaqGS:NTRA) Welcomes Former National Cancer Institute Director Back to Board

Why Is Natera (NTRA) Stock Soaring Today

StockStory

8 months ago

Why Is Natera (NTRA) Stock Soaring Today

Natera Announces Enrollment of First Patients in the HEROES Clinical Trial in Metastatic HER2+ Breast Cancer

Business Wire

8 months ago

Natera Announces Enrollment of First Patients in the HEROES Clinical Trial in Metastatic HER2+ Breast Cancer

Share on Social Networks: